Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries.
BACKGROUND
No formal comparison has been made between the pediatric post-highly active antiretroviral therapy (HAART) outcomes of resource-limited and developed countries.


OBJECTIVE
To systematically quantify and compare major baseline characteristics and clinical end points after HAART between resource-limited and developed settings.


METHODS
Published articles and abstracts (International AIDS Society 2009, Conference on Retroviruses and Opportunistic Infections 2010) were examined from inception (first available publication for each search engine) to March 2010. Publications that contained data on post-HAART mortality, weight-for-age z score (WAZ), CD4 count, or viral load (VL) changes in pediatric populations were reviewed. Selected studies met the following criteria: (1) patients were younger than 21 years; (2) HAART was given (≥ 3 antiretroviral medications); and (3) there were >20 patients. Data were extracted for baseline age, CD4 count, VL, WAZ, and mortality, CD4 and virologic suppression over time. Studies were categorized as having been performed in a resource-limited country (RLC) or developed country (DC) on the basis of the United Nations designation. Mean percentage of deaths per cohort and deaths per 100 child-years, baseline CD4 count, VL, WAZ, and age were calculated for RLCs and DCs and compared by using independent samples t tests.


RESULTS
Forty RLC and 28 DC publications were selected (N = 17 875 RLCs; N = 1835 DC). Mean percentage of deaths per cohort and mean deaths per 100 child-years after HAART were significantly higher in RLCs than DCs (7.6 vs 1.6, P < .001, and 8.0 vs 0.9, P < .001, respectively). Mean baseline CD4% was 12% in RLCs and 23% in DCs (P = .01). Mean baseline VLs were 5.5 vs 4.7 log(10) copies per mL in RLCs versus DCs (P < .001).


CONCLUSIONS
Baseline CD4% and VL differ markedly between DCs and RLCs, as does mortality after pediatric HAART. Earlier diagnosis and treatment of pediatric HIV in RLCs would be expected to result in better HAART outcomes.
University of Washington School of Medicine, Seattle, Washington 98195-6340, USA. lilipv@u.washington.edu
Elizabeth
E
Peacock-Villada
Barbra A
BA
Richardson
Grace C
GC
John-Stewart
D023241:Antiretroviral Therapy, Highly Active / Q000379:methods / Q000639:trends*; D002648:Child; D002986:Clinical Trials as Topic / Q000639:trends; D019049:Developed Countries; D003906:Developing Countries; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D006295:Health Resources / Q000639:trends*; D006801:Humans; D016896:Treatment Outcome
AIDS. 1999 Sep 10;13(13):1653-8
10509566
Pediatrics. 2005 Feb;115(2):e173-82
15629958
AIDS. 2007 Aug 20;21(13):1805-10
17690580
Clin Infect Dis. 2007 May 15;44(10):1361-7
17443476
Eur J Pediatr. 2001 Oct;160(10):611-6
11686506
AIDS. 1998 Nov 12;12(16):2155-9
9833856
Pediatrics. 2004 Nov;114(5):e604-11
15492356
AIDS Care. 2007 Oct;19(9):1088-94
18058392
Pediatrics. 2007 Mar;119(3):e705-15
17308244
J Infect Dis. 2000 Nov;182(5):1385-93
11010839
N Engl J Med. 1997 Sep 11;337(11):725-33
9287227
Pediatr Infect Dis J. 2010 Apr;29(4):340-5
20019645
J Pediatr. 2000 Jun;136(6):780-8
10839877
Clin Diagn Lab Immunol. 2001 Sep;8(5):943-8
11527808
Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):977-84
18629557
N Engl J Med. 2005 Dec 1;353(22):2325-34
16319381
J Infect Dis. 2000 Jul;182(1):96-103
10882586
AIDS. 2004 Jun;18 Suppl 2:S27-34
15319741
Pediatr Infect Dis J. 1999 Jul;18(7):650-2
10440447
Pediatr Infect Dis J. 2008 Nov;27(11):993-8
18818556
Pediatr Infect Dis J. 2000 Dec;19(12):1148-53
11144374
Clin Infect Dis. 2008 Feb 15;46(4):507-15
18199042
Int J Infect Dis. 2008 Nov;12(6):e33-8
18573672
J Antimicrob Chemother. 2008 Jun;61(6):1336-9
18343800
Arch Dis Child. 2007 Mar;92(3):234-41
16670122
Clin Infect Dis. 2004 Sep 1;39(5):725-31
15356789
JAMA. 2005 May 11;293(18):2213-20
15886376
JAMA. 2000 Jan 26;283(4):492-8
10659875
S Afr Med J. 2004 Aug;94(8):643-6
15352588
N Engl J Med. 1997 May 8;336(19):1343-9
9134874
Pediatr Infect Dis J. 2002 Jun;21(6):518-25
12182375
Pediatr Infect Dis J. 2001 Oct;20(10):941-6
11642627
AIDS. 2006 Nov 28;20(18):2315-9
17117017
Rev Panam Salud Publica. 2009 Jan;25(1):51-5
19341524
Arch Pediatr Adolesc Med. 2002 Jun;156(6):568-73
12038889
Pediatr Infect Dis J. 2006 Jan;25(1):59-64
16395105
AIDS. 2003 Nov 7;17(16):2331-6
14571184
J Infect Dis. 2000 Dec;182(6):1769-73
11069252
Pediatrics. 2007 Apr;119(4):838-45
17403860
Scand J Infect Dis. 2007;39(9):799-804
17701719
Lancet. 2001 Nov 24;358(9295):1760-5
11734232
J Neurol. 2006 Dec;253(12):1615-24
17093898
Pediatr Infect Dis J. 2004 Aug;23(8):713-8
15295220
N Engl J Med. 2008 Nov 20;359(21):2233-44
19020325
BMC Pediatr. 2008 Dec 06;8:53
19061515
Pediatr Infect Dis J. 2002 Jul;21(7):653-9
12237598
Infection. 2000 Sep;28(5):287-96
11073135
AIDS. 1999 May 28;13(8):1005-6
10371191
Pediatrics. 1998 Mar;101(3 Pt 1):335-43
9480994
Pediatr Infect Dis J. 2007 Jan;26(1):86-8
17195716
AIDS. 2006 Oct 3;20(15):1955-60
16988517
Am J Public Health. 2007 Jun;97(6):974-7
17463375
Pediatrics. 2007 May;119(5):e1116-20
17420261
Pediatrics. 1999 Nov;104(5):e56
10545582
AIDS Patient Care STDS. 2003 Feb;17(2):65-73
12639289
Clin Infect Dis. 2007 Feb 15;44(4):599-604
17243067
AIDS Behav. 2009 Feb;13(1):23-32
18654845
J Infect. 2005 Jun;50(5):404-11
15907548
Clin Infect Dis. 1999 May;28(5):1109-18
10452644
J Infect Dis. 2006 Apr 1;193(7):954-62
16518757
Pediatr Infect Dis J. 2006 May;25(5):420-6
16645506
Int J Epidemiol. 2009 Oct;38(5):1207-14
19036797
Pediatr Infect Dis J. 2001 May;20(5):511-7
11368109
Pediatr Infect Dis J. 2002 Feb;21(2):119-25
11840078
AIDS Patient Care STDS. 2004 Jun;18(6):355-63
15294086
J Med Assoc Thai. 2005 Nov;88 Suppl 8:S221-31
16856444
AIDS. 2007 Jul 31;21(12):1607-15
17630556
AIDS. 2004 Jan 23;18(2):237-45
15075541
J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):594-8
18043313
AIDS Res Hum Retroviruses. 2007 Oct;23(10):1208-14
17961106
Indian Pediatr. 2007 Jul;44(7):519-21
17684304
BMC Pediatr. 2007 Mar 17;7:13
17367540
J Infect Dis. 2001 Apr 1;183(7):1116-20
11237839
Eur J Pediatr. 2000 Oct;159(10):778-82
11039136
Cad Saude Publica. 2007;23 Suppl 3:S414-23
17992347
An Pediatr (Barc). 2005 Sep;63(3):199-202
16219271
Pediatrics. 2007 Nov;120(5):e1134-40
17954553
West Indian Med J. 2004 Oct;53(5):322-6
15675498
AIDS Res Hum Retroviruses. 2000 Aug 10;16(12):1113-21
10954886
Pediatr Infect Dis J. 1998 Jun;17(6):495-9
9655541
Pediatrics. 2002 Feb;109(2):E25
11826235
Clin Infect Dis. 2009 Dec 15;49(12):1915-27
19916798
Pediatr Infect Dis J. 2004 Aug;23(8):695-700
15295217
AIDS. 2008 Jul 11;22(11):1333-43
18580613
J Trop Pediatr. 2011 Apr;57(2):109-19
20601692
Pediatrics. 2007 Aug;120(2):e416-23
17646352
N Engl J Med. 1999 Dec 16;341(25):1874-81
10601506
Pediatr Infect Dis J. 2008 May;27(5):431-7
18382386
J Antimicrob Chemother. 2008 Jan;61(1):183-90
18025025
Pediatr Infect Dis J. 2003 Oct;22(10):863-7
14551485
J Infect Dis. 2007 May 15;195(10):1411-8
17436220
Pediatrics. 2007 Oct;120(4):e856-61
17846147
J Trop Pediatr. 2009 Aug;55(4):225-32
18522999
Pediatrics. 2002 Apr;109(4):e61
11927734
Indian Pediatr. 2005 Aug;42(8):789-96
16141480
Pediatr Infect Dis J. 2009 Feb;28(2):159-61
19106779
Arch Pediatr. 2005 Apr;12(4):404-9
15808429
Clin Infect Dis. 2002 Apr 1;34(7):991-1001
11880966
Clin Infect Dis. 2005 Feb 15;40(4):604-8
15712085
J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):187-93
17693883
J Int AIDS Soc. 2010 Aug 06;13:31
20691049
Pediatr Infect Dis J. 2007 Sep;26(9):799-805
17721374
J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):523-31
18989227
Braz J Infect Dis. 2004 Dec;8(6):419-23
15880232
AIDS. 2004 Sep 24;18(14):1905-13
15353976
Pediatr Infect Dis J. 2003 Jan;22(1):56-62
12544410
AIDS Res Hum Retroviruses. 2004 Sep;20(9):927-31
15585079
JAMA. 2000 Jul 12;284(2):190-7
10889592
Trans R Soc Trop Med Hyg. 2006 Jan;100(1):19-23
16154608
Pediatr Infect Dis J. 1999 Aug;18(8):682-9
10462336
J Infect Dis. 2005 Aug 1;192(3):445-55
15995958
Indian Pediatr. 2007 May;44(5):339-43
17536133
Clin Infect Dis. 2002 Apr 1;34(7):1008-16
11880968
AIDS. 2005 Aug 12;19(12):1243-9
16052078
Bull World Health Organ. 2006 Feb;84(2):145-50
16501733
Pediatrics. 2008 Apr;121(4):e827-35
18332076
J Trop Pediatr. 2009 Jun;55(3):155-9
18829638
S Afr Med J. 2005 Nov;95(11):812
16344865
Pediatrics. 1998 Jul;102(1 Pt 1):101-9
9651421
N Engl J Med. 2001 Nov 22;345(21):1522-8
11794218
Clin Infect Dis. 2006 Jul 15;43(2):243-52
16779753
Lancet Infect Dis. 2008 Aug;8(8):477-89
18652994
AIDS. 1999 Jan 14;13(1):81-7
10207548
JAMA. 2006 Jul 19;296(3):292-300
16849662
AIDS. 1997 Oct;11(12):F107-11
9342062
AIDS. 2007 Jan 30;21(3):351-9
17255742
Expert Rev Anti Infect Ther. 2008 Oct;6(5):585-9
18847398
J Natl Med Assoc. 2008 Jul;100(7):821-5
18672559
Pediatrics. 2007 May;119(5):e1142-8
17452493
Lancet. 2002 Mar 2;359(9308):733-40
11888583
N Engl J Med. 2004 Jun 10;350(24):2471-80
15190139
BMC Pediatr. 2008 Nov 21;8:52
19025581
JAMA. 2007 Oct 24;298(16):1888-99
17954540
Pediatrics. 2006 Feb;117(2):273-83
16452344
Trans R Soc Trop Med Hyg. 2007 May;101(5):511-6
17197006
J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):311-7
17356470
J Infect Dis. 2004 Jul 15;190(2):271-9
15216461
BMC Pediatr. 2008 Oct 02;8:39
18831747
J Trop Pediatr. 2006 Feb;52(1):3-11
15947012
Minerva Pediatr. 2006 Oct;58(5):483-90
17008860
AIDS. 2008 Jan 11;22(2):249-55
18097227
J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):488-94
15764966
Antimicrob Agents Chemother. 2008 Sep;52(9):3276-83
18625762
Bull World Health Organ. 2000;78(10):1200-6
11100615
Int J Epidemiol. 2008 Jun;37(3):474-80
17998240
J Infect Dis. 1999 Mar;179(3):576-83
9952363
Clin Infect Dis. 2007 Oct 1;45(7):918-24
17806062
Int J Infect Dis. 2002 Mar;6(1):9-16
12044295
J Pediatr. 1998 Mar;132(3 Pt 1):543-6
9544920
AIDS. 2001 Jan 26;15(2):241-3
11216933
Pediatr Infect Dis J. 2005 Oct;24(10):880-5
16220085
Pediatr Infect Dis J. 2005 Sep;24(9):793-800
16148846
Arch Pediatr. 2007 Oct;14(10):1178-82
17531452
J Infect Dis. 2001 Jul 15;184(2):201-5
11424019
AIDS. 2009 Mar 13;23(5):597-604
19194272
Pediatr Infect Dis J. 1997 Oct;16(10):968-74
9380474
J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):418-25
17099313
J Acquir Immune Defic Syndr. 2010 Jan;53(1):86-94
20035164
IAVI Rep. 2005 Nov-Dec;9(5):20
16544373
J Pediatr (Rio J). 2006 Jul-Aug;82(4):260-5
16881008
AIDS. 2004 Sep 24;18(14):1915-24
15353977
Lancet. 2004 Oct 2-8;364(9441):1236-43
15464184
Clin Infect Dis. 2008 Jun 1;46(11):1751-60
18426371
Lancet. 2003 Dec 20;362(9401):2045-51
14697803
Pediatrics. 2001 Oct;108(4):E72
11581480
Antimicrob Agents Chemother. 2004 Mar;48(3):979-84
14982792
Clin Infect Dis. 2005 Apr 15;40(8):1181-7
15791520
AIDS. 1999 Dec 24;13(18):2523-32
10630521
Acta Paediatr. 2007 Jul;96(7):1090-4
17577344
AIDS Res Hum Retroviruses. 2008 Jul;24(7):911-7
18593341